Constanza Savid-Frontera

5PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursLiquid biopsiesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicities.

Payal Goala, Yongliang Zhang, Cooper Sailer

|Oct 16, 2024
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.

Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera

|Jan 09, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.

Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton

|Nov 16, 2021
Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic.

Constanza Savid-Frontera, Maria E Viano, Natalia S Baez

Pageof 1